US 12,419,782 B2
Apparatus and methods for improved nasal cavity treatments
Brian Fahey, Menlo Park, CA (US); and William Jason Fox, San Mateo, CA (US)
Assigned to Arrinex, Inc., Redwood City, CA (US)
Appl. No. 17/638,541
Filed by Arrinex, Inc., Redwood City, CA (US)
PCT Filed Sep. 17, 2020, PCT No. PCT/US2020/051177
§ 371(c)(1), (2) Date Feb. 25, 2022,
PCT Pub. No. WO2021/055544, PCT Pub. Date Mar. 25, 2021.
Claims priority of provisional application 62/901,656, filed on Sep. 17, 2019.
Prior Publication US 2022/0313484 A1, Oct. 6, 2022
Int. Cl. A61F 7/12 (2006.01); A61B 18/02 (2006.01); A61F 7/00 (2006.01)
CPC A61F 7/123 (2013.01) [A61B 18/02 (2013.01); A61F 2007/0006 (2013.01); A61F 2007/0056 (2013.01); A61F 2007/126 (2013.01)] 12 Claims
OG exemplary drawing
 
1. A cryotherapy device, comprising:
an elongated shaft; and
a cryotherapy delivery member coupled to a distal end of the elongated shaft, wherein the cryotherapy delivery member comprises a plurality of plates and a plurality of rods coupling the plurality of plates to the distal end of the elongated shaft,
wherein the cryotherapy delivery member is configured to apply, from a fixed position in a nasal cavity, by one or more of the plurality of plates contacting a nasal wall, cryotherapy to at least one nerve in the nasal cavity or at least one branch of a nerve in the nasal cavity.